Breaking News
Sunday , November 19 2017
Home / Tag Archives: Merck Co

Tag Archives: Merck Co

USFDA accepts Sun Pharma’s application for Tildrakizumab

The US Food and Drug Administration (USFDA) has accepted Sun Pharmaceutical Industries’ Biologics License Application (BLA) for tildrakizumab. The USFDA filing acceptance follows the acceptance of the regulatory filing of tildrakizumab by the European Medicines Agency (EMA) in March 2017. Tildrakizumab is an investigational IL-23p19 inhibitor being evaluated for the ... Read More »